CALGARY, AB, Feb. 10, 2022 /CNW/ - Universal Ibogaine
Inc. (TSXV: IBO) ("UI" or the "Company") a
life sciences company with a mission to transform the world of
addiction treatment through medicalized ibogaine and a state of the
art ongoing care program, is pleased to advise it has entered a
Memorandum of Understand (the "MOU") with Osoyoos Indian
Band Development Corporation ("OIBDC").
Osoyoos Indian Band is a world leader in indigenous
business. OIBDC has generated hundreds of millions of dollars
of revenue on its lands through tourism, leasing and construction
related endeavours, joint ventures and partnerships with globally
recognized brands such as Hyatt and Jackson-Triggs. The
Osoyoos Indian Band has 540 members and its territory spans over
32000 acres of the warmest lands in Canada located in the Okanagan valley of
British Columbia, between
Osoyoos and Oliver.
The MOU has as its objective, participation of both
organizations for purpose and profit, to construct an ibogaine
centered detox clinic and holistic aftercare treatment centre. The
partners will act as collaborators in bridging economic and social
models that respect Indigenous ways while leveraging Western
scientific practices. Partnership opportunities may include
leasing or joint venture with possibilities to convert existing
space or new construction. The development timeline will
coincide with the planned Health Canada approval process of the
Universal Ibogaine treatment protocol.
Chief Ian Campbell – UI
Chairman
Chief Ian Campbell of the Squamish
Nation and UI Board Chair shared, "The primary focus for Universal
Ibogaine is to bring this life saving medicine to those who need it
as quickly as possible. This potential partnership between UI
and the Osoyoos Indian Band demonstrates what is possible when we
work together towards a solution."
Chief Clarence Louie – Osoyoos
Indian Band
Clarence Louie is a globally
recognized indigenous leader and has served as the elected Chief of
the Osoyoos Indian Band for close to 40 years. He is a sought-after
speaker and holder of innumerable awards, including an Order of
Canada and membership in the
Canadian Business Hall of Fame. Chief Clarence stated, "We
are pleased with the opportunity to partner on this venture and
bring opportunities for economic inclusion and deep healing for
many people to our lands."
Nick Karos – CEO Universal
Ibogaine
Nick Karos, recently appointed CEO
of Universal Ibogaine added, "We are excited for this developing
relationship. The Osoyoos Indian Band is one of the most
proactive and forward-looking groups we have had the opportunity to
engage with. We have a big job ahead, and partners like
Osoyoos Indian Band add huge credibility to our mission and can aid
in diversifying our business opportunities and the planned ultimate
deployment of the ibogaine addiction treatment protocol."
Mike Campol – COO Osoyoos
Indian Band Development Corporation
"The opioid epidemic is a public health emergency. We have to
do better than opioid substitution therapy. What we have here
is an opportunity to be part of a transformation in the way that
society treats those who suffer, views plant medicine, and
understands indigenous culture. We are pleased to see where
this collaboration can take us."
About Universal Ibogaine Inc.
UI is a life sciences company, with a mission to demonstrate the
safety and efficacy of its ibogaine based drug detox protocol
through a Canadian Clinical Trial, and ultimately to utilize that
protocol around the globe through future licensing
agreements. UI is concurrently developing a state of the art
holistic addiction treatment protocol at its Kelburn Clinic that,
which when paired with the planned ibogaine detox protocol, is
intended to revolutionize the way we treat addiction and
drastically improve the lives of individuals and families affected
by addiction.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING
STATEMENTS
This news release may contain forward-looking statements and
information. Forward-looking information is frequently
characterized by words such as "plans", "expect", "project",
"intend", "will", "believe", "anticipate", "estimate", "scheduled",
"potential", or other similar words, or statements that certain
events or conditions "may", "should" or "could" occur. The
forward-looking statements and information are based on certain key
expectations and assumptions made by UI. Although UI
believes that the expectations and assumptions on which the
forward-looking statements are based are reasonable, undue
reliance should not be placed on the forward-looking statements
because UI can give no assurance that they will prove to be
correct.
Since forward-looking statements address future events and
conditions, by their very nature they involve inherent risks and
uncertainties. Actual results could differ materially from those
currently anticipated due to a number of factors and risks, which
include, but are not limited to, risks that required regulatory
approvals are not obtained. The reader is cautioned that
assumptions used in the preparation of such information, although
considered reasonable by UI at the time of preparation, may prove
to be incorrect and readers are cautioned not to place undue
reliance on forward-looking information, which speaks only to
conditions as of the date hereof. UI does not undertake any
obligation to release publicly any revisions to forward-looking
information contained herein to reflect events or circumstances
that occur after the date hereof or to reflect the occurrence of
unanticipated events, except as may be required under applicable
securities laws.
Related
Links
https://universalibogaine.com
SOURCE Universal Ibogaine Inc.